RP

Ranjana Parmanand Verma

Active Director Director DIN 07619173
DIN 07619173 First appointment Oct 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value •••• Premium profile

About Ranjana Parmanand Verma

Data last updated:

Ranjana Parmanand Verma is a Director at Phylambin Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Phylambin Pharmaceuticals Private Limited reported revenue of ₹12.5 Lakh (FY 2025).

DIN 07619173
Primary Designation Director
Industry Trading
First Appointment 29 Oct 2016
Oldest Company Age 9 yrs
Largest company Phylambin Pharmaceuticals Private Limited · ₹12.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Oct 20162016₹12.5 Lakh (FY 2025)Active

Board colleagues of Ranjana Parmanand Verma

Directorship timeline

Open interactive timeline →
Phylambin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ranjana Parmanand Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjana Parmanand Verma

Ranjana Parmanand Verma currently holds 1 directorship: Phylambin Pharmaceuticals Private Limited (Director, since 29 Oct 2016, revenue ₹12.5 Lakh (FY 2025)).

Ranjana Parmanand Verma was first appointed on 29 Oct 2016 as Director at Phylambin Pharmaceuticals Private Limited.

The current boards of Ranjana Parmanand Verma's companies include Ritika Verma (Phylambin Pharmaceuticals Private Limited), Suman Kumar (Phylambin Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available